M. Şerban

1.3k total citations
53 papers, 706 citations indexed

About

M. Şerban is a scholar working on Hematology, Immunology and Molecular Biology. According to data from OpenAlex, M. Şerban has authored 53 papers receiving a total of 706 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Hematology, 11 papers in Immunology and 7 papers in Molecular Biology. Recurrent topics in M. Şerban's work include Hemophilia Treatment and Research (29 papers), Platelet Disorders and Treatments (14 papers) and Blood Coagulation and Thrombosis Mechanisms (10 papers). M. Şerban is often cited by papers focused on Hemophilia Treatment and Research (29 papers), Platelet Disorders and Treatments (14 papers) and Blood Coagulation and Thrombosis Mechanisms (10 papers). M. Şerban collaborates with scholars based in Romania, United Kingdom and Germany. M. Şerban's co-authors include L. Rusen, Liselotte S. Ebbesen, Barbara A. Konkle, R. Bianco, Toshko Lissitchkov, Elisabeth Erhardtsen, A. Gringeri, LG Mantovani, Cindy Leissinger and Claude Négrier and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

M. Şerban

48 papers receiving 687 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Şerban Romania 12 609 161 80 71 50 53 706
Bhakti Mehta United States 9 335 0.6× 150 0.9× 60 0.8× 33 0.5× 47 0.9× 21 399
Tomás José González‐López Spain 11 318 0.5× 90 0.6× 50 0.6× 37 0.5× 23 0.5× 43 424
CK Kasper United States 12 487 0.8× 127 0.8× 94 1.2× 51 0.7× 41 0.8× 21 585
Elizabeth O’Flaherty Australia 9 315 0.5× 116 0.7× 50 0.6× 64 0.9× 27 0.5× 15 390
Saverio Ladogana Italy 13 305 0.5× 84 0.5× 89 1.1× 44 0.6× 39 0.8× 33 432
Luz Tarín‐Arzaga Mexico 10 316 0.5× 80 0.5× 40 0.5× 56 0.8× 31 0.6× 34 405
Annemieke Willemze United States 9 281 0.5× 59 0.4× 71 0.9× 71 1.0× 25 0.5× 27 434
Jeffrey R. Andolina United States 10 218 0.4× 90 0.6× 30 0.4× 76 1.1× 41 0.8× 30 345
Nauman M. Butt United Kingdom 7 253 0.4× 299 1.9× 151 1.9× 36 0.5× 12 0.2× 16 454
Harshraj Leuva United States 5 345 0.6× 77 0.5× 26 0.3× 70 1.0× 53 1.1× 13 409

Countries citing papers authored by M. Şerban

Since Specialization
Citations

This map shows the geographic impact of M. Şerban's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Şerban with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Şerban more than expected).

Fields of papers citing papers by M. Şerban

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Şerban. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Şerban. The network helps show where M. Şerban may publish in the future.

Co-authorship network of co-authors of M. Şerban

This figure shows the co-authorship network connecting the top 25 collaborators of M. Şerban. A scholar is included among the top collaborators of M. Şerban based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Şerban. M. Şerban is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Maftei, Nicoleta-Maricica, et al.. (2025). HLA-B27 Status in Rheumatic Diseases: Clinical and Immunological Differences Between Positive and Negative Patients—A Comparative Study. Biomedicines. 13(8). 1996–1996. 1 indexed citations
3.
Şerban, M., et al.. (2024). Emergency-Driven Multiple Simultaneous Invasive Procedures in Haemophilia. Life. 14(9). 1172–1172. 1 indexed citations
4.
Şerban, M., et al.. (2023). Rare within Rare: A Girl with Severe Haemophilia A and Turner Syndrome. Journal of Clinical Medicine. 12(23). 7437–7437.
5.
Țigu, Adrian Bogdan, Rareş Drulă, Alina‐Andreea Zimța, et al.. (2023). RNA sequencing suggests that non‐coding RNAs play a role in the development of acquired haemophilia. Journal of Cellular and Molecular Medicine. 27(13). 1790–1796. 2 indexed citations
6.
Bălănescu, Paul, Claudia Cristina Tărniceriu, Oana Viola Bădulescu, et al.. (2023). Large Intron Inversions in Romanian Patients with Hemophilia A—First Report. Medicina. 59(10). 1821–1821.
7.
Zimța, Alina‐Andreea, Cătălin Constantinescu, Diana Gulei, et al.. (2021). The Possible Non-Mutational Causes of FVIII Deficiency: Non-Coding RNAs and Acquired Hemophilia A. Frontiers in Medicine. 8. 654197–654197. 3 indexed citations
8.
Gál, Krisztina, Diana Cenariu, M. Şerban, et al.. (2021). Mobile Health Technology for the Personalized Therapy of Hemophilia. Frontiers in Medicine. 8. 711973–711973. 5 indexed citations
9.
Chiriţă-Emandi, Adela, et al.. (2020). Challenges in reporting pathogenic/potentially pathogenic variants in 94 cancer predisposing genes - in pediatric patients screened with NGS panels. Scientific Reports. 10(1). 223–223. 19 indexed citations
10.
Castaman, Giancarlo, Alessandra Borchiellini, Elena Santagostino, et al.. (2020). Non-Compartment and compartmental pharmacokinetics, efficacy, and safety of Kedrion FIX concentrate. European Journal of Pharmaceutical Sciences. 153. 105485–105485. 1 indexed citations
11.
Escobar, Miguel A., Ramin Tehranchi, Faraizah Abdul Karim, et al.. (2016). Low‐factor consumption for major surgery in haemophilia B with long‐acting recombinant glycoPEGylated factor IX. Haemophilia. 23(1). 67–76. 21 indexed citations
12.
Şerban, M., et al.. (2014). Risiken und Herausforderungen orthopädischer invasiver Eingriffe bei Hämophilie in Ländern mit eingeschränkten Ressourcen. Hämostaseologie. 34. 1 indexed citations
13.
Elze, Markus C., Oana Ciocârlie, Stephan Kloeß, et al.. (2014). Dendritic cell reconstitution is associated with relapse-free survival and acute GVHD severity in children after allogeneic stem cell transplantation. Bone Marrow Transplantation. 50(2). 266–273. 13 indexed citations
14.
Gulácsy, Vera, Beáta Soltész, Edit Gyimesi, et al.. (2014). A novel large deletion and single nucleotide insertion in the Wiskott–Aldrich syndrome protein gene. European Journal Of Haematology. 95(1). 93–98. 2 indexed citations
15.
Şerban, M., et al.. (2014). Risks and challenges of orthopaedic invasive interventions in haemo -philia in a low-resource country. Hämostaseologie. 34(S 01). S30–S35. 1 indexed citations
16.
17.
Borte, Michael, Małgorzata Pac, M. Şerban, et al.. (2011). Efficacy and Safety of Hizentra®, a New 20% Immunoglobulin Preparation for Subcutaneous Administration, in Pediatric Patients with Primary Immunodeficiency. Journal of Clinical Immunology. 31(5). 752–61. 42 indexed citations
18.
Uscătescu, Valentina, et al.. (2011). Development of inhibitors in haemophilia. Hämostaseologie. 31(S 01). S20–S23. 1 indexed citations
19.
Doroș, Gabriela, et al.. (2009). Infected urachal cyst and acute appendicitis in a 1 year and 11 month old girl. Medical Ultrasonography. 11(3). 79–83. 1 indexed citations
20.
Konkle, Barbara A., Liselotte S. Ebbesen, Elisabeth Erhardtsen, et al.. (2007). Randomized, prospective clinical trial of recombinant factor VIIa for secondary prophylaxis in hemophilia patients with inhibitors. Journal of Thrombosis and Haemostasis. 5(9). 1904–1913. 259 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bhakti Mehta Breakdown of academic impact, for papers by Tomás José González‐López Breakdown of academic impact, for papers by CK Kasper Breakdown of academic impact, for papers by Elizabeth O’Flaherty Breakdown of academic impact, for papers by Saverio Ladogana Breakdown of academic impact, for papers by Luz Tarín‐Arzaga Breakdown of academic impact, for papers by Annemieke Willemze Breakdown of academic impact, for papers by Jeffrey R. Andolina Breakdown of academic impact, for papers by Nauman M. Butt Breakdown of academic impact, for papers by Harshraj Leuva
Rankless by CCL
2026